XTL Biopharmaceuticals Ltd (XTLB)
1.83
+0.06
(+3.39%)
USD |
NASDAQ |
Nov 21, 16:00
1.67
-0.16
(-8.74%)
Pre-Market: 20:00
XTL Biopharmaceuticals Max Drawdown (5Y): 92.62% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 92.62% |
| September 30, 2024 | 92.62% |
| August 31, 2024 | 92.62% |
| July 31, 2024 | 92.62% |
| June 30, 2024 | 92.62% |
| May 31, 2024 | 92.62% |
| April 30, 2024 | 92.62% |
| March 31, 2024 | 92.62% |
| February 29, 2024 | 92.62% |
| January 31, 2024 | 92.62% |
| December 31, 2023 | 93.05% |
| November 30, 2023 | 94.22% |
| October 31, 2023 | 94.22% |
| September 30, 2023 | 94.22% |
| August 31, 2023 | 94.22% |
| July 31, 2023 | 94.93% |
| June 30, 2023 | 95.14% |
| May 31, 2023 | 95.14% |
| April 30, 2023 | 95.57% |
| March 31, 2023 | 95.57% |
| February 28, 2023 | 95.57% |
| January 31, 2023 | 95.57% |
| December 31, 2022 | 95.57% |
| November 30, 2022 | 95.57% |
| October 31, 2022 | 95.57% |
| Date | Value |
|---|---|
| September 30, 2022 | 95.57% |
| August 31, 2022 | 95.57% |
| July 31, 2022 | 95.57% |
| June 30, 2022 | 95.57% |
| May 31, 2022 | 95.57% |
| April 30, 2022 | 95.57% |
| March 31, 2022 | 95.57% |
| February 28, 2022 | 95.57% |
| January 31, 2022 | 95.57% |
| December 31, 2021 | 95.57% |
| November 30, 2021 | 95.57% |
| October 31, 2021 | 95.57% |
| September 30, 2021 | 95.57% |
| August 31, 2021 | 95.57% |
| July 31, 2021 | 95.57% |
| June 30, 2021 | 95.57% |
| May 31, 2021 | 95.57% |
| April 30, 2021 | 95.57% |
| March 31, 2021 | 95.57% |
| February 28, 2021 | 95.57% |
| January 31, 2021 | 95.57% |
| December 31, 2020 | 95.57% |
| November 30, 2020 | 95.57% |
| October 31, 2020 | 95.57% |
| September 30, 2020 | 95.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.62%
Minimum
Jan 2024
95.57%
Maximum
Nov 2019
94.92%
Average
95.57%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Compugen Ltd | 97.28% |
| Pluri Inc | 96.65% |
| BioLine Rx Ltd | 97.41% |
| Can Fite Biofarma Ltd | 99.32% |
| BiomX Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -8.041 |
| Beta (5Y) | 1.211 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 112.7% |
| Historical Sharpe Ratio (5Y) | 0.0673 |
| Historical Sortino (5Y) | 0.284 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.72% |